Business Standard

Thursday, December 26, 2024 | 04:04 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Madras HC maintains injunction barring Patanjali from using term Coronil

Court came down heavily on Patanjali for attempting to make profits by exploiting fear of Covid-19

Patanjali coronil
Premium

The Order followed a petition filed by Patanjali Ayurved Ltd, seeking vacation of an ex-parte interim injunction granted by the Court on July 17

T E Narasimhan Chennai
The Madras High Court today refused to vacate an injunction restraining Patanjali from using the term Coronil to market its immunity-boosting tablets against Covid-19. Justice C V Karthikeyan of the High Court came down heavily on Patanjali in in his order today, for attempting to profit by exploiting the fear of Covid-19. He directed the firm to pay Rs 10 lakh towards costs to Cancer Institute, Adyar in Chennai and the Government Yoga & Naturopathy hospital.

The Order followed a petition filed by Patanjali Ayurved Ltd, seeking vacation of an ex-parte interim injunction granted by the Court on July 17,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in